UFF
BIIB icon

USA Financial Formulas’s Biogen BIIB Stock Holding History

USA Financial Formulas’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6
Closed -$1.39K – 277
2024
Q2 		$1.39K Hold
6
– – ﹤0.01% 291
2024
Q1 		$1.29K Sell
6
-36
-86% -$8.43K ﹤0.01% 298
2023
Q4 		$10.9K Sell
42
-8,504
-100% -$2.09M ﹤0.01% 252
2023
Q3 		$2.2M Buy
8,546
+38
+0.4% +$10.2K 3.28% 5
2023
Q2 		$2.42M Sell
8,508
-3,977
-32% -$1.18M 3.72% 3
2023
Q1 		$3.47M Buy
+12,485
New +$3.45M 5.62% 1
2022
Q3 		$6K Buy
24
+19
+380% +$4.04K 0.01% 120
2022
Q2 		$1K Hold
5
– – ﹤0.01% 237
2022
Q1 		$1K Buy
+5
New +$1.09K ﹤0.01% 272
2021
Q4 		– Sell
-3,595
Closed -$1.02M – 379
2021
Q3 		$1.02M Buy
+3,595
New +$1.18M 0.91% 56
2020
Q4 		– Sell
-26
Closed -$7K – 326
2020
Q3 		$7K Sell
26
-19
-42% -$5.3K 0.01% 162
2020
Q2 		$12K Sell
45
-11,600
-100% -$3.49M 0.01% 76
2020
Q1 		$3.68M Buy
+11,645
New +$3.53M 2.35% 5
2019
Q1 		– Sell
-14,571
Closed -$5.15M – 143
2018
Q4 		$5.15M Buy
+14,571
New +$4.65M 1.28% 22
2018
Q1 		– Sell
-12,849
Closed -$4.09M – 316
2017
Q4 		$4.09M Buy
+12,849
New +$4.12M 0.97% 28

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

USA Financial Formulas's BIIB Position: Q3 2024 in Review

USA Financial Formulas sold out of Biogen (BIIB) in Q3 2024, closing a stake of 6 shares — an estimated $1.39K sold.

USA Financial Formulas first reported a position in BIIB in Q4 2017 and held it in 15 quarters. The position peaked at $5.15M in Q4 2018. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • USA Financial Formulas reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • USA Financial Formulas sold 6 Biogen shares in Q3 2024, an estimated $1.39K.
  • USA Financial Formulas first reported a position in Biogen in Q4 2017 and held it in 15 quarters.
  • USA Financial Formulas's Biogen position peaked at $5.15M in Q4 2018.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on USA Financial Formulas's 13F filing for Q3 2024, filed 8 Oct 2024.